Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 20, 2022
Aragen announced that it will operationalize its formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023. The 12,000 square feet new facility will strengthen the company’s ability to deliver clinical supplies to ...
read more
Aragen Life Sciences, formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked its transition to a new brand identity. With a legacy of over 20 years of partnering with innovator...
read more
Friday, February 24, 2017
Aramark is increasing its capacity to provide cleanroom services to customers throughout the Southwest with its new 34,350 square foot processing plant in McKinney, Texas.
read more
Thursday, December 19, 2024
Aramis Biotechnologies Inc. and Biodextris Inc. announced a strategic partnership that will leverage the expertise of both companies to ensure efficient downstream manufacturing of clinical materials for Aramis' leading product candidate, a seasonal ...
read more
Thursday, November 14, 2024
Aravax announced it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more
Friday, February 02, 2018
TransPerfect Life Sciences announced that ARCA Biopharma has selected TransPerfect’s Trial Interactive eTMF solution as their enterprise platform for clinical trials.
read more
ARCA biopharma announced that Medtronic has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement with ARCA for an additional year to April 2019.
read more
Arch Biopartners Inc. announced that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
read more
Arch Biopartners engaged a global CRO to initiate and conduct a Phase II trial in the U.S. for its lead drug Metablok for COVID-19 complications.
read more
Arch Biopartners has hired Dalton Pharma Services to perform the good manufacturing practice campaign for Metablok, the company's drug candidate for preventing acute kidney injury.
read more
ArcherDX announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for AstraZeneca's targeted immuno-oncology therapeutics.
read more
ArcherDX is entering into a collaboration with Bristol Myers to utilize PCM assays to understand the potential benefits of MRD detection in cancer patients treated with immunotherapy.
read more
Archimica has started the operation of its expanded development laboratories at its Lodi (Italy) site. This recent $1.6 Million investment has more than doubled the company's capabilities to realize API and GMP Building Block custom process ...
read more
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
read more